BendBio provides the core inertial microfluidics engine for next-generation cell therapy manufacturing systems.

The Bottleneck: The growth of cell therapy has outpaced the evolution of its core processing tools. The industry remains reliant on legacy platforms like centrifugation, which are harsh on cells, difficult to automate, and introduce unacceptable process variability.

Our Solution: We break this bottleneck with a proven, purpose-built platform for cell sorting, washing, concentration, and filtration. Our technology, exclusively licensed from Massachusetts General Hospital (MGH), enables a closed, continuous-flow process that delivers unmatched consistency, superior cell yield, purity, and viability.

Engineered for OEM Integration: We empower our partners—instrument manufacturers and life science companies—by providing a validated, integration-ready subsystem. Our compact, scalable modules accelerate your time-to-market, de-risk your supply chain through our ISO 13485-certified manufacturing, and free your team to focus on instrument design and workflow innovation.

Let's build your next-generation system.

BendBio

Org chart

Teams

Offices

BendBio

Org chart

Teams

Offices

Related companies